Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate Gel for Repeat Treatment of Actinic Keratosis
NCT01600014Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- May 2012
- Primary completion
- Feb 2014
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by LEO Pharma. Started May 2012; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01600014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600014.